Mattias Ekstedt

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Topics

Alcohol Consumption

Top Venues

Hepatology communications

Liver international : official journal of the International Association for the Study of the Liver

Scandinavian journal of gastroenterology

BMC gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Henrik Podéus, Christian Simonsson, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Peter Lundberg, William Lövfors, Gunnar Cedersund
A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth. NPJ digital medicine 7 (1) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Cecilia Jönsson, Martin Bergram, Stergios Kechagias, Patrik Nasr, Mattias Ekstedt
Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant. Scandinavian journal of gastroenterology 59 (6) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Henrik Podéus, Christian Simonsson, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Peter Lundberg, William Lövfors, Gunnar Cedersund
A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth. NPJ digital medicine 7 (1) (2024)
Henrik Podéus, Christian Simonsson, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Peter Lundberg, William Lövfors, Gunnar Cedersund
A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth. NPJ digital medicine 7 (1) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Cecilia Jönsson, Martin Bergram, Stergios Kechagias, Patrik Nasr, Mattias Ekstedt
Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant. Scandinavian journal of gastroenterology (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Cecilia Jönsson, Martin Bergram, Stergios Kechagias, Patrik Nasr, Mattias Ekstedt
Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant. Scandinavian journal of gastroenterology 59 (6) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology communications 7 (1) (2023)
Lina Gruneau, Stergios Kechagias, Per Sandström, Mattias Ekstedt, Martin Henriksson
Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease. Hepatology communications 7 (7) (2023)
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology communications 7 (1) (2023)
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology communications 7 (1) (2023)
Patrik Nasr, Mikael Fredrik Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjögren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol. BMC gastroenterology 23 (1) (2023)
Christina Gummesson, Stina Alm, Anna Cederborg, Mattias Ekstedt, Jarl Hellman, Hans Hjelmqvist, Magnus Hultin, Katharina Jood, Charlotte Leanderson, Bertil Lindahl, Riitta Möller, Björn E Rosengren, Anders Själander, Peter J Svensson, Stefan Särnblad, Alexander Tejera
Entrustable professional activities (EPAs) for undergraduate medical education - development and exploration of social validity. BMC medical education 23 (1) (2023)
Patrik Nasr, Mikael Fredrik Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjögren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol. BMC gastroenterology 23 (1) (2023)
Patrik Nasr, Mikael Fredrik Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjögren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol. BMC gastroenterology 23 (1) (2023)
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology communications 7 (1) (2023)
Tove Törnqvist, Mattias Ekstedt, Sally Wiggins, Madeleine Abrandt Dahlgren
Connecting knowledge: First-year health care students' learning in early interprofessional tutorials. Journal of interprofessional care (2023)
Patrik Nasr, Mikael Fredrik Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjögren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg, Stergios Kechagias, Olof Dahlqvist Leinhard, Mattias Ekstedt
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol. BMC gastroenterology 23 (1) (2023)
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology communications 7 (1) (2023)
Christina Gummesson, Stina Alm, Anna Cederborg, Mattias Ekstedt, Jarl Hellman, Hans Hjelmqvist, Magnus Hultin, Katharina Jood, Charlotte Leanderson, Bertil Lindahl, Riitta Möller, Björn E Rosengren, Anders Själander, Peter J Svensson, Stefan Särnblad, Alexander Tejera
Entrustable professional activities (EPAs) for undergraduate medical education - development and exploration of social validity. BMC medical education 23 (1) (2023)
Sami Qadri, Noora Ahlholm, Ida Lønsmann, Paola Pellegrini, Anni Poikola, Panu K Luukkonen, Kimmo Porthan, Anne Juuti, Henna Sammalkorpi, Anne K Penttilä, Roberta D'Ambrosio, Giorgio Soardo, Diana Julie Leeming, Morten Asser Karsdal, Johanna T Arola, Stergios Kechagias, Serena Pelusi, Mattias Ekstedt, Luca Vittorio Valenti, Hannes Hagström, Hannele Yki-Järvinen
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. The Journal of clinical endocrinology and metabolism 107 (5) (2022)
Oscar Silfvergren, Christian Simonsson, Mattias Ekstedt, Peter Lundberg, Peter Gennemark, Gunnar Cedersund
Digital twin predicting diet response before and after long-term fasting. PLoS computational biology 18 (9) (2022)
Wile Balkhed, Fredrik O Åberg, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias
Repeated measurements of non-invasive fibrosis tests to monitor the progression of non-alcoholic fatty liver disease: A long-term follow-up study. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones (Athens, Greece) 21 (3) (2022)
Elke Ericson, Linnéa Bergenholm, Anne-Christine Andréasson, Carly I Dix, Jane Knöchel, Sara F Hansson, Richard G Lee, Jennifer Schumi, Madeleine Antonsson, Ola Fjellström, Patrik Nasr, Mathias Liljeblad, Björn C L Carlsson, Stergios Kechagias, Daniel Lindén, Mattias Ekstedt
Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Hepatology communications 6 (10) (2022)
Olivier Govaere, Simon J Cockell, Dina Tiniakos, Rachel Queen, Ramy Younes, Michele Vacca, Leigh Alexander, Federico Ravaioli, Jeremy Palmer, Salvatore Petta, Jerome Boursier, Chiara Rosso, Katherine Johnson, Kristy Wonders, Christopher P Day, Mattias Ekstedt, Matej Oresic, Rebecca Darlay, Heather J Cordell, Fabio Marra, Antonio Vidal-Puig, Pierre Bedossa, Jörn Markus Schattenberg, Karine Clement, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Ann K Daly, Quentin Mark Anstee
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Science translational medicine 12 (572) (2021)
Patrik Nasr, Fredrik Iredahl, Nils Dahlström, Karin Rådholm, Pontus Henriksson, Gunnar Cedersund, Olof Dahlqvist Leinhard, Tino Ebbers, Joakim Alfredsson, Carl-Johan Carlhäll, Peter Lundberg, Stergios Kechagias, Mattias Ekstedt
Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol. BMC gastroenterology 21 (1) (2021)
Hannes Hagström, Dawei Bu, Patrik Nasr, Mattias Ekstedt, Hannes Hegmar, Stergios Kechagias, Ningyan Zhang, Zhiqiang An, Per Stål, Philipp E Scherer
Serum levels of endotrophin are associated with nonalcoholic steatohepatitis. Scandinavian journal of gastroenterology 56 (4) (2021)
Martin Bergram, Patrik Nasr, Fredrik Iredahl, Stergios Kechagias, Karin Rådholm, Mattias Ekstedt
Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care. Scandinavian journal of gastroenterology (2021)
Mikael Fredrik Forsgren, Patrik Nasr, Markus Karlsson, Nils Dahlström, Bengt Norén, Simone Ignatova, Ralph Sinkus, Gunnar Cedersund, Olof Dahlqvist Leinhard, Mattias Ekstedt, Stergios Kechagias, Peter Lundberg
Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastography. Scandinavian journal of gastroenterology 55 (7) (2020)
Patrik Nasr, Mats Fredrikson, Mattias Ekstedt, Stergios Kechagias
The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (5) (2020)
Elena Buzzetti, Andrew Hall, Mattias Ekstedt, Roberta Manuguerra, Marta Guerrero Misas, Claudia Covelli, Gioacchino Leandro, Tu Vinh Luong, Stergios Kechagias, Emanuel K Manesis, Massimo Pinzani, Amar P Dhillon, Emmanuel A Tsochatzis
Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 49 (9) (2019)